🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Keith Syson Chan

Houston Methodist

ORCID: 0000-0003-1670-8508

Also affiliated with Methodist Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571
Top 100%
0DataRank
Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Papers

Driven by 12 papers — median percentile 0. Top paper: “Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy”.

Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy

Gastroenterology(2022)10.1053/j.gastro.2022.06.027
N/A
0.652DataRank · unranked
76 citations

Jianxin Wang, John Davelaar, Andrew Baker, Keyu Li, Nan Niu +17 more

RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis

Cancer Letters(2021)10.1016/j.canlet.2021.08.008
N/A
0.505DataRank · unranked
28 citations

Yu‐Cheng Lee, Michael Ittmann, Fang‐Tsyr Lin, Keith Syson Chan, Weei-Chin Lin +1 more

circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment

Nature Communications(2022)10.1038/s41467-022-34872-8
N/A
0.464DataRank · unranked
21 citations

Emily Ko, Connor Barrett, Marco De Simone, Xianzhi Lin, Marina T. Broz +11 more

Targeting ketone body metabolism in mitigating gemcitabine resistance

JCI Insight(2024)10.1172/jci.insight.177840
N/A
0.293DataRank · unranked
5 citations

Sungyong You, Minhyung Kim, Sandrine Billet, Johanna ten Hoeve, Gabrielle Gonzales +5 more

Characterizing molecular subtypes of high-risk nonmuscle-invasive bladder cancer in African American patients.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.527
N/A
0DataRank · unranked
0 citations

Sungyong You, Minhyung Kim, Steven G. Widen, Alexander Yu, Eduardo Eyzaguirre +10 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571
Top 100%
0DataRank
Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Figshare(2023)10.1158/1078-0432.22486556.v1
Top 100%
0DataRank
Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.c.6532346.v1
Top 100%
0DataRank
Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.04.013
N/A
0DataRank · unranked
14 citations

Minhyung Kim, Steven G. Widen, Alexander Yu, Gloria C. Galván, Yunhee Choi-Kuaea +12 more

An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer

Nature Communications(2021)10.1038/s41467-021-25103-7
N/A
0DataRank · unranked
181 citations

Nathan Ing, Jasmine Plummer, Charles J. Rosser, Bassem Ben Cheikh, Catherine Oh +7 more

Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti–PD-L1 Immune Checkpoint Therapy

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac140
N/A
0DataRank · unranked
15 citations

Minhyung Kim, Xen Ping Hoi, Yu Cheng Lee, Li Wang, David Spetzler +7 more

Plasminogen activator inhibitor-2(PAI-2) overexpression supportsbladder cancer developmentin PAI-1 knockout mice in N-butyl-N-(4-hydroxybutyl)-nitrosamine- induced bladdercancer mouse model

Journal of Translational Medicine(2020)10.1186/s12967-020-02239-6
N/A
0DataRank · unranked
31 citations

Kazukuni Hayashi, Yoshiko Shimizu, Nari Kim, Yutaro Tsukikawa, Runpu Chen +9 more